Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

IONIS PHARMACEUTICALS, INC.

Filed by LMH STRATEGIC SOLUTIONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 18, 2025
Income
$20,000.00
Expenses
Not reported
Filing UUID
5fb69b0a-68f3-46e2-bcf7-497ec2c8d292
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to the implementation of H.R.5547/S.476 - Maintaining Investments in New Innovation Act and H.R.7384 - Creating Hope Reauthorization Act of 2024. Pediatric Review Reauthorization. H.R.946 - ORPHAN Cures Act. H.R.1509/S.752 - Accelerating Kids Access to Care Act of 2025.

Literal federal measure citations: H.R.5547, S.476, H.R.7384, H.R.946, H.R.1509, S.752

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.